In another meta-analysis of eight RCTs of DPP-4 inhibitors and metformin (as an initial combination therapy or monotherapy) in patients with T2DM, DPP-4 inhibitors were found to be safe and effective in controlling blood glucose [84]. Here, DPP4 is linked to type 2 diabetes mellitus.